Sulfated polysaccharides extracted from sea algae as potential antiviral drugs

General Pharmacology

Volumn 29, Issue 4, 1997, Pages 497-511

  Witvrouw, M ^a   De Clercq, E ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CD4 ANTIGEN; DERMATAN SULFATE; DEXTRAN SULFATE; GALACTAN; HEPARIN; MANNAN; PENTOSAN POLYSULFATE; POLYSACCHARIDE SULFATE; ZIDOVUDINE;

ALGA; ANTIVIRAL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; DRUG ISOLATION; DRUG RESISTANCE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION; SULFATION; SYNCYTIUM; VIRUS ADSORPTION; VIRUS REPLICATION;

EID: 0030813482     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00563-0     Document Type: Review

References (96)

1. Andrei G., De Clercq E. Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res. 14:1990;287-300.
2. Andrei G., Snoeck R., Goubau P., Desmyter J., De Clercq E. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus. Eur. J. Microbiol. Infect. Dis. 10:1991;1026-1033.
3. Andrei G., De Clercq E. Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral Res. 22:1993;45-75.
4. Baba M., Nakajima M., Schols D., Pauwels R., Balzarini J., De Clercq E. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res. 9:1988;335-343. . a.
5. Baba M., Snoeck R., Pauwels R., De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus and human immunodeficiency virus. Antimicrob. Agents Chemother. 32:1988;1742-1745. . b.
6. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;6132-6136. . c.
7. Baba M., Schols D., De Clercq E., Pauwels R., Nagy M., Györgyi-Edelényi J., Löw M., Görög S. Novel sulfated polymers are highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrob. Agents Chemother. 34:1990;134-138. . a.
8. Baba M., Schols D., Pauwels R., Nakashima H., De Clercq E. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation. a new strategy towards AIDS chemotherapy J. AIDS. 3:1990;493-499. . b.
9. Bagasra O., Lischner H. W. Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. J. Infect. Dis. 158:1988;1084-1087.
10. Balzarini J., Neyts J., Schols D., Hosoya M., Van Damme E., Peumans W., De Clercq E. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res. 18:1992;191-207.
11. Batinic D., Robey F. A. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:1992;6664-6671.
12. Buckheit R. W. Jr., Germany-Decker J., Hollingshead M. G., Allen L. B., Shannon W. M., Janssen P. A. J., Chirigos M. A. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents. AIDS Res. Hum. Retrovir. 9:1993;1097-1106.
13. Busso M., Resnick L. Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides. Antimicrob. Agents Chemother. 34:1990;1991-1995.
14. Callahan L. N., Phelan M., Mallinson M., Norcross M. A. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65:1991;1543-1550.
15. Cardin A. D., Taylor D. L., Krstenansky J. L., Tyms A. S., Jackson R. L. A heparin which binds to the envelope glycoprotein gp120 inhibits human immunodeficiency virus replication. Trans. Assoc. Am. Phys. 102:1989;101-109.
16. Cronn R. C., Whitmer J. D., North T. W. RNaseH activity associated with reverse transcriptase from feline immunodeficiency virus. J. Virol. 66:1992;1215-1218.
17. Damonte E., Neyts J., Pujol C. A., Snoeck R., Andrei G., Ikeda S., Witvrouw M., Haines H., Matulewicz M. C., Cerezo A., Coto C. E., De Clercq E. Antiviral activity of a sulfated polysaccharide from the red seaweed Nothogenia fastigiata. Biochem. Pharmac. 47:1994;2187-2192.
18. De Clercq E. (1993) Anti-HIV activity of sulfated polysaccharides. In Carbohydrates and Carbohydrate Polymers, Analysis, Biotechnology, Modification, Antiviral, Biomedical and Other Applications. (Edited by Yalpani M.). ATL Press.
19. DiNinno V., McCandless E. L. The chemistry and immunochemistry of carrageenans from Eucheuma and related algal species. Carbohyd. Res. 66:1978;85-95.
20. Ehresmann D. W., Dieg E. F., Hatch M. T., DiSalvo L. H., Vedros N. A. Antiviral substances from California marine algea. J. Phycol. 13:1977;37-40.
21. Eppley R. W. Sodium exclusion and potassium retention by the red marine alga, Porphyra perforata. J. Gen. Physiol. 41:1958;901-911.
22. Eriksson B. F. H., Schinazi R. F. Combinations of 3′-azido-3′-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus in vitro. Antimicrob. Agents Chemother. 33:1989;663-669.
23. Fogg G. E. The Metabolism of Algae. 1953;Methuen, London.
24. Gallaher W. R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 50:1987;327-328.
25. Gerber P., Dutcher J. D., Adams E. V., Sherman J. H. Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps. Proc. Soc. Exp. Biol. Med. 99:1958;590-593.
26. Grönwall A., Ingelman B., Mosimann H. A dextran sulphuric acid ester with heparin activity. Uppsala Lakarefören. Forh. 50:1945;397-404.
27. Hartshorn K. L., Vogt M. W., Chou T. C., Blumberg R. S., Byington R., Schooley R. T., Hirsch M. S. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Antimicrob. Agents Chemother. 31:1987;168-172.
28. Haseltine W. A. Replication and pathogenesis of the AIDS virus. J. AIDS. 1:1988;217-240.
29. Hattori T., Koito A., Takatsuki K., Kido H., Katunuma N. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 248:1989;48-52.
30. Hayashi S., Fine R. L., Chou T.-C., Currens M. J., Broder S., Mitsuya H. In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of anti-retroviral 2′,3′-dideoxynucleosides and virus-binding inhibitors. Antimicrob. Agents Chemother. 34:1990;82-88.
31. Hosoya M., Balzarini J., Shigeta S., De Clercq E. Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins. Antimicrob. Agents Chemother. 35:1991;2515-2520.
32. Jackson R. L., Busch S. J., Cardin A. D. Glycosaminoglycans. molecular properties, protein interactions, and role in physiological processes Physiol. Rev. 71:1991;481-539.
33. Jeanloz R. W., Stoffyn P. J., Trémège M. Chemical structure of β-heparin. Fed. Proc. 16:1957;201.
34. Johnson V. A., Barlow M. A., Chou T. C., Fisher R. A., Walker B. D., Hirsch M. S., Schooley R. T. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3′-azido-3′-deoxythymidine. J. Infect. Dis. 159:1989;837-844. . a.
35. Johnson V. A., Walker B. D., Barlow M. A., Paradis T. J., Chou T. C., Hirsch M. S. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3′-azido-3′-deoxythymidine. Antimicrob. Agents Chemother. 33:1989;53-57. . b.
36. Jurkiewicz E., Panse P., Jentsch K.-D., Hartmann H., Hunsmann G. In vitro anti-HIV-1 activity of chondroitin polysulfate. AIDS. 3:1989;423-427.
37. Kari B., Gehrz R. Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. J. Gen. Virol. 74:1993;255-264.
38. Kjellén L., Lindahl U. Proteoglycans. structures and interactions Annu. Rev. Biochem. 60:1991;443-475.
39. Lange J. M. A., Karam M., Piot P. Boost for vaginal microbicides against HIV. Lancet. 341:1993;1356.
40. Larder B. A., Darby G., Richman D. D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 243:1989;1731-1734.
41. Lederman S., Gulick R., Chess L. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J. Immunol. 143:1989;1149-1154.
42. Lederman S., Bergmann J. E., Cleary A. M., Yellin M. J., Fusco P. J., Chess L. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (V3) of gp120 are chemically distinct. AIDS Res. Hum. Retrovir. 8:1992;1599-1610.
43. Lorentsen K. J., Hendrix C. W., Collins J. M., Kornhauser D. M., Petty B. G., Klecker R. W., Flexner C., Eckel R. H., Lietman P. S. Dextran sulfate is poorly absorbed after oral administration. Ann. Intern. Med. 111:1989;561-566.
44. Lüscher-Mattli M., Glück R. Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppress influenza virus replication in vivo. Antiviral Res. 14:1990;39-50.
45. Lüscher-Mattli M., Glück R., Kempf C., Zanoni-Grassi M. A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus. Arch. Virol. 130:1993;317-326.
46. Lycke E., Johansson M., Svennerholm B., Lindahl U. Binding of herpes simplex virus to cellular heparan sulfate, an initial step in the adsorption process. J. Gen. Virol. 72:1991;1131-1137.
47. Marbet R., Winterstein A. Probleme der Blutgerinnung. β-Heparin, ein neuer, blutgerinnungshemmender Mucoitinschwefelsäureester. Helv. Chim. Acta. 34:1951;2311.
48. Mastromarino P., Conti C., Petruzziello R., Lapadula R., Orsi N. Effect of polyions on the early events of Sindbis virus infection of Vero cells. Arch. Virol. 121:1991;19-27. . a.
49. Mastromarino P., Seganti L., Petruzziello R., Gabrieli R., Divizia M., Panà A., Orsi N. Influence of polyanions on the early steps of enterovirus infection. J. Chemother. 3:1991;203-208. . b.
50. Matulewicz M. C., Cerezo A. S. Water-soluble sulfated polysaccharides from the red seaweed Chaetangium fatigiatum. Analysis of the system and structures of the α-D-(1→3)-linked mannans. Carbohyd. Pol. 7:1987;121-132.
51. Mbemba E., Chams V., Gluckman J.-C., Klatzmann D., Gattegno L. Molecular interactions between HIV-1 major envelope glycoprotein and dextran sulfate. Biochim. Biophys. Acta. 1138:1992;62-67.
52. Meyer K., Chaffee E. The mucopolysaccharides of skin. J. Biol. Chem. 138:1941;491.
53. + cells Science. 240:1988;646-649.
54. Moelling K., Schulze T., Diringer H. Inhibition of human immunodeficiency virus type 1 RNaseH by sulfated polyanions. J. Virol. 63:1989;5489-5491.
55. Montefiori D. C., Robison W. E., Modliszewski A., Rowland J. M., Schuffman S. S., Mitchell W. M. Differential inhibition of HIV-1 cell binding and HIV-1-induced syncytium formation by low molecular weight sulphated polysaccharides. J. Antimicrob. Chemother. 25:1990;313-318.
56. Morris E. R., Rees D. A., Thom D., Welsh E. J. Conformation and intermolecular interactions of carbohydrate chains. J. Supramol. Struct. 6:1977;259-274.
57. Nakashima H., Kido Y., Kobayashi N., Motoki Y., Neushul M., Yamamoto N. Antiretroviral activity in a marine red alga; reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica. J. Cancer Res. Clin. Oncol. 113:1987;413-416. . a.
58. Nakashima H., Kido Y., Kobayashi N., Motoki Y., Neushul M., Yamamoto N. Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae. Antimicrob. Agents Chemother. 31:1987;1524-1528. . b.
59. Nakashima H., Yoshida O., Baba M., De Clercq E., Yamamoto N. Anti-HIV activity of dextran sulfate as determined under different experimental conditions. Antiviral Res. 11:1989;233-246.
60. Neyts J., De Clercq E. Effect of polyanionic compounds on intracutaneous and intravaginal herpes virus infection in mice. impact on the search for vaginal microbicides with anti-HIV activity J. AIDS Hum. Retrovir. 10:1995;8-12.
61. Neyts J., Snoeck R., Schols D., Balzarini J., Esko J. D., Van Schepdael A., De Clercq E. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology. 189:1992;48-58.
62. Nkowane B. M. Prevalence and incidence of HIV infection in Africa. a review of data published in 1990 AIDS. 5(suppl.):1991;S7-S16.
63. Otake T., Schols D., Witvrouw M., Naesens L., Nakashima H., Moriya T., Kurita H., Matsumoto K., Ueba N., De Clercq E. Modified cyclodextrin sulfates (mCDS11) have potent inhibitory activity against HIV and high oral bioavailability. Antiviral Chem. Chemother. 5:1993;155-161.
64. Parish C. R., Low L., Warren H. S., Cunningham A. L. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region. J. Immunol. 145:1990;1188-1195.
65. Patel M., Yanagishita M., Roderiquez G., Bou-Habib D. C., Oravecz T., Hascall V. C., Norcross M. A. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retrovir. 9:1993;167-174.
66. Pearce-Pratt R., Phillips D. M. Studies of adhesion of lymphotropic cells. implications for sexual transmission of HIV Biol. Reprod. 48:1993;431-445.
67. Percival E., McDowel R. H. Chemistry and Enzymology of Marine Algal Polysaccharides. 1967;Academic Press, New York.
68. Rees D. A. Carbohydrate sulfates. Annu Rep Chem Soc (Lond). 1965.
69. Richards J. T., Kern E. R., Glasgow L. A., Overall J. C. Jr., Deig E. F., Hatch M. T. Antiviral activity of extracts from marine algae. Antimicrob. Agents Chemother. 14:1978;24-30.
70. Robbins A. K., Watson R. J., Whealy M. E., Hays W. W., Enquist L. W. Characterization of a pseudorabies virus glycoprotein gene with homology to herpes simplex virus type 1 and type 2 glycoprotein C. J. Virol. 58:1986;339-347.
71. Sawitzky D., Hampl H., Habermehl K.-O. Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins. J. Gen. Virol. 71:1990;1221-1225.
72. + cells. J. AIDS. 2:1989;10-15. . a.
73. Schols D., Baba M., Pauwels R., Desmyter J., De Clercq E. Specific interaction of autrintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA. 86:1989;3322-3326. . b.
74. + cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry. J. Gen. Virol. 70:1989;2397-2408. . c.
75. Schols D., De Clercq E., Balzarini J., Baba M., Witvrouw M., Hosoya M., Andrei G., Snoeck R., Neyts J., Pauwels R., Nagy M., Györgyi-Edelényi J., Machovich R., Horváth I., Löw M., Görög S. Sulphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses. Antiviral Chem. Chemother. 1:1990;233-240. . a.
76. Schols D., Pauwels R., Desmyter J., De Clercq E. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology. 175:1990;556-561. . b.
77. Schols D., De Clercq E., Witvrouw M., Nakashima H., Snoeck R., Pauwels R., Van Schepdael A., Claes P. Sulphated cyclodextrins are potent anti-HIV agents acting synergistically with 2′,3′-dideoxynucleoside analogues. Antiviral Chem. Chemother. 2:1991;45-53.
78. Schols D., Pauwels R., Witvrouw M., Desmyter J., De Clercq E. Differential activity of polyanionic compounds and castanospermine against HIV replication and HIV-induced syncytium formation depending on virus strain and cell type. Antiviral Chem. Chemother. 3:1992;23-29.
79. Skinner M. A., Ting R., Langlois A. J., Weinhold K. J., Lyerly H. K., Javaherian K., Matthews T. J. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res. Hum. Retrovir. 4:1988;187-197.
80. Smith M. S., Brian E. L., De Clercq E., Pagano J. S. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3′-azido-3′-deoxythymidine. Antimicrob. Agents Chemother. 33:1989;1482-1486.
81. St. Clair M. H., Martin J. L., Tudor-Williams G., Bach M. C., Vavro C. L., King D. M., Kellam P., Kemp S. D., Larder B. A. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science. 245:1991;1557-1559.
82. Stegmann T., Doms R. W., Helenius A. Protein-mediated membrane fusion. Annu. Rev. Biophys. Chem. 18:1989;187-211.
83. Stig Hansen J.-E., Nielsen C., Vestergaard B. F. Inhibition of human immunodeficiency virus 1 (HIV-1) and herpes simplex virus 1 (HSV-1) infectivity with a broad range of lectins. Scand. J. Infect. Dis. 23:1991;425-430.
84. Sugawara I., Itoh W., Kimura S., Mori S., Shimada K. Further characterization of sulfated homopolysaccharides as anti-HIV agents. Experientia. 45:1989;996-998.
85. Swiss patent 293,566 (1955) Sulfuric acid esters of xylan. 49, 1787h.
86. Sydow G., Klöcking H.-P. Effect of pentosan polysulfate (SP54) on the reverse transcriptase activity of several retroviruses. Biomed. Biochim. Acta. 46:1987;527-530.
87. Thiele B., Braig H. R., Ehm I., Kunze R., Ruf B. Influence of sulfated carbohydrates on the accessibility of CD4 and other CD molecules on the cell surface and implications for human immunodeficiency virus infection. Eur. J. Immunol. 19:1989;1161-1164.
88. Ueno R. and Kuno S. (1987) Dextran sulfate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet i, 1379.
89. Vaheri A. Heparin and related polyionic substances as virus inhibitors. Acta Pathol. Microbiol. Scand. 171(suppl.):1964;7.
90. Witvrouw M., Baba M., Balzarini J., Pauwels R., De Clercq E. Establishment of a bioassay to determine serum levels of dextran sulfate and pentosan polysulfate, two potent inhibitors of human immunodeficiency virus. J AIDS. 3:1990;343-347.
91. Witvrouw M., Schols D., Andrei G., Snoeck R., Hosoya M., Pauwels R., Balzarini J., De Clercq E. Antiviral activity of low-MW dextran sulphate (derived from dextran MW 1000) compared to dextran sulphate samples of higher MW. Antiviral Chem. Chemother. 2:1991;171-179.
92. Witvrouw M., Schols D., Andrei G., Snoeck R., Ikeda S., Pauwels R., Van Schepdael A., Arnout J., Claes P., Desmyter J., De Clercq E. New polyacetal polysulphate active against human immunodeficiency virus and other enveloped viruses. Antiviral Chem. Chemother. 3:1992;351-360.
93. Witvrouw M., Este J. A., Quinones Mateu M. E., Reymen D., Andrei G., Snoeck R., Ikeda S., Pauwels R., Vittori Bianchini N., Desmyter J., De Clercq E. Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses. Antiviral Chem. Chemother. 5:1994;297-303. . a.
94. Witvrouw M., Desmyter J., De Clercq E. Polysulfates as inhibitors of HIV and other enveloped viruses. Antiviral Chem. Chemother. 5:1994;345-359. . b.
95. WuDunn D., Spear P. G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:1989;52-58.
96. Yarchoan R. H., Mitsuya H., Myers C. E., Broder S. Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N. Engl. J. Med. 321:1989;726-738.